254 related articles for article (PubMed ID: 21332573)
1. Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis.
Garcia HH; Lescano AG; Lanchote VL; Pretell EJ; Gonzales I; Bustos JA; Takayanagui OM; Bonato PS; Horton J; Saavedra H; Gonzalez AE; Gilman RH;
Br J Clin Pharmacol; 2011 Jul; 72(1):77-84. PubMed ID: 21332573
[TBL] [Abstract][Full Text] [Related]
2. Cysticidal Efficacy of Combined Treatment With Praziquantel and Albendazole for Parenchymal Brain Cysticercosis.
Garcia HH; Lescano AG; Gonzales I; Bustos JA; Pretell EJ; Horton J; Saavedra H; Gonzalez AE; Gilman RH;
Clin Infect Dis; 2016 Jun; 62(11):1375-9. PubMed ID: 26984901
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial.
Garcia HH; Gonzales I; Lescano AG; Bustos JA; Zimic M; Escalante D; Saavedra H; Gavidia M; Rodriguez L; Najar E; Umeres H; Pretell EJ;
Lancet Infect Dis; 2014 Aug; 14(8):687-695. PubMed ID: 24999157
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic optimisation of the treatment of neurocysticercosis.
Sotelo J; Jung H
Clin Pharmacokinet; 1998 Jun; 34(6):503-15. PubMed ID: 9646011
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic variability of anthelmintics: implications for the treatment of neurocysticercosis.
Jung-Cook H
Expert Rev Clin Pharmacol; 2012 Jan; 5(1):21-30. PubMed ID: 22142156
[TBL] [Abstract][Full Text] [Related]
6. Routine drug and food interactions during antihelminthic treatment of neurocysticercosis: a reason for the variable efficacy of albendazole and praziquantel?
Romo ML; Carpio A; Kelvin EA
J Clin Pharmacol; 2014 Apr; 54(4):361-7. PubMed ID: 24443292
[TBL] [Abstract][Full Text] [Related]
7. Albendazole Sulfoxide Plasma Levels and Efficacy of Antiparasitic Treatment in Patients With Parenchymal Neurocysticercosis.
Arroyo G; Bustos JA; Lescano AG; Gonzales I; Saavedra H; Rodriguez S; Pretell EJ; Bonato PS; Lanchote VL; Takayanagui OM; Horton J; Gonzalez AE; Gilman RH; Garcia HH;
Clin Infect Dis; 2019 Nov; 69(11):1996-2002. PubMed ID: 30715265
[TBL] [Abstract][Full Text] [Related]
8. Cysticidal activity of praziquantel-mebendazole combination: In vitro and in vivo studies.
Francisca PA; Javier LF; Guadalupe PH; Fernanda GM; Nelly C; Helgi JC; Iliana GH; Susana RI
Acta Trop; 2020 Feb; 202():105238. PubMed ID: 31669532
[TBL] [Abstract][Full Text] [Related]
9. [Chemotherapy of cysticercosis. Review about its pharmacokinetics and toxicology].
Herrera LA; Benítez-Bribiesca L; Sotelo J; Ostrosky-Wegman P
Gac Med Mex; 2000; 136(5):477-89. PubMed ID: 11080931
[TBL] [Abstract][Full Text] [Related]
10. Sensitive in vitro system to assess morphological and biochemical effects of praziquantel and albendazole on Taenia solium cysts.
Mahanty S; Paredes A; Marzal M; Gonzalez E; Rodriguez S; Dorny P; Guerra-Giraldez C; Garcia HH; Nash T
Antimicrob Agents Chemother; 2011 Jan; 55(1):211-7. PubMed ID: 21041508
[TBL] [Abstract][Full Text] [Related]
11. Combination therapy with albendazole and praziquantel versus albendazole alone in children with seizures and single lesion neurocysticercosis: a randomized, placebo-controlled double blind trial.
Kaur S; Singhi P; Singhi S; Khandelwal N
Pediatr Infect Dis J; 2009 May; 28(5):403-6. PubMed ID: 19325515
[TBL] [Abstract][Full Text] [Related]
12. Murine cysticercosis model: influence of the infection time and the time of treatment on the cysticidal efficacy of albendazole and praziquantel.
Palomares-Alonso F; Palencia Hernández G; Rojas-Tomé IS; Jung-Cook H; Pinzón-Estrada E
Exp Parasitol; 2015 Feb; 149():1-6. PubMed ID: 25500213
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of oxfendazole, praziquantel and albendazole against cystic echinococcosis: a randomized clinical trial in naturally infected sheep.
Gavidia CM; Gonzalez AE; Barron EA; Ninaquispe B; Llamosas M; Verastegui MR; Robinson C; Gilman RH
PLoS Negl Trop Dis; 2010 Feb; 4(2):e616. PubMed ID: 20186332
[TBL] [Abstract][Full Text] [Related]
14. Do albendazole-loaded lipid nanocapsules enhance the bioavailability of albendazole in the brain of healthy mice?
Fabbri J; Espinosa JP; Pensel PE; Medici SK; Gamboa GU; Benoit JP; Elissondo MC
Acta Trop; 2020 Jan; 201():105215. PubMed ID: 31600525
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic interaction between albendazole sulfoxide enantiomers and antiepileptic drugs in patients with neurocysticercosis.
Lanchote VL; Garcia FS; Dreossi SA; Takayanagui OM
Ther Drug Monit; 2002 Jun; 24(3):338-45. PubMed ID: 12021623
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Combination Therapy of Albendazole and Praziquantel vs Albendazole Monotherapy in Children With Persistent Neurocysticercosis: A Randomized Controlled Trial.
Singh K; Saini AG; Khandelwal N; Singhi P
J Child Neurol; 2022 Apr; 37(5):366-372. PubMed ID: 35213246
[TBL] [Abstract][Full Text] [Related]
17. Medical management of neurocysticercosis.
Takayanagui OM; Odashima NS; Bonato PS; Lima JE; Lanchote VL
Expert Opin Pharmacother; 2011 Dec; 12(18):2845-56. PubMed ID: 22082143
[TBL] [Abstract][Full Text] [Related]
18. Albendazole-praziquantel interaction in healthy volunteers: kinetic disposition, metabolism and enantioselectivity.
Lima RM; Ferreira MA; de Jesus Ponte Carvalho TM; Dumêt Fernandes BJ; Takayanagui OM; Garcia HH; Coelho EB; Lanchote VL
Br J Clin Pharmacol; 2011 Apr; 71(4):528-35. PubMed ID: 21395645
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of diverse antiparasitic treatments for cysticercosis in the pig model.
Gonzalez AE; Bustos JA; Jimenez JA; Rodriguez ML; Ramirez MG; Gilman RH; Garcia HH;
Am J Trop Med Hyg; 2012 Aug; 87(2):292-6. PubMed ID: 22855760
[TBL] [Abstract][Full Text] [Related]
20. Clinical pharmacokinetics of albendazole in children with neurocysticercosis.
Jung H; Sánchez M; González-Astiazarán A; Martínez JM; Suástegui R; González-Esquivel DF
Am J Ther; 1997 Jan; 4(1):23-6. PubMed ID: 10423586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
